Veterinary Diagnostics Market Size & Growth Forecast 2027–2036, By Segments (Animal Type, Product, End-use, Testing Category), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Veterinary Diagnostics Market size was around USD 9.3 billion in 2026 and is slated to grow at a 10.45% CAGR from 2027 to 2036, crossing USD 25.13 billion by 2036. The industry revenue for 2027 is calculated at USD 10.12 billion.

• Base Year Value (2026): USD 9.3 billion
• CAGR (2027-2036): 10.45%
• Forecast Year Value (2036): USD 25.13 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Veterinary Diagnostics Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held a 40.55% market share in 2026, supported by established animal healthcare infrastructure, broad diagnostic testing availability, and consistently high spending on companion animal care.
  • Asia Pacific is forecast to expand at an 11.31% CAGR, driven by greater animal health awareness, expanding veterinary services, and increasing diagnostic testing across companion animal and livestock care.

• Segment Momentum:

  • Companion Animals held a 62.22% share in 2026, supported by frequent veterinary visits, routine screening, disease monitoring, and greater use of preventive diagnostic testing.
  • Consumables, Reagents & Kits are the fastest-growing product segment because routine diagnostic workflows require continuous replenishment, with rising testing volumes driving recurring demand rather than one-time purchases.

• Market Expansion Drivers:

  • Rising pet adoption and preventive animal healthcare increasing demand for routine diagnostic testing.
  • Growing incidence of zoonotic and livestock diseases accelerating adoption of advanced veterinary diagnostics.
  • Expanding molecular diagnostic capabilities improving accuracy and speed of veterinary disease detection.

• Leading Market Participants:

  Prominent players in the veterinary diagnostics market include IDEXX Laboratories, Inc. (United States), Zoetis Inc. (United States), Antech Diagnostics, Inc. (United States), FUJIFILM Corporation (Japan), Virbac S.A. (France), Esaote S.p.A. (Italy), Embark Veterinary, Inc. (United States), Innovative Diagnostics SAS (France), Agrolabo S.p.A. (Italy).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 9.3 billion
  • 2027 Estimated Market Size: USD 10.12 billion.
  • Projected Market Size: USD 25.13 billion by 2036
  • Growth Forecasts: 10.45% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Companion Animals (Animal Type) | Consumables, Reagents & Kits (Product) | Veterinarians (End-use) | Clinical Chemistry (Testing Category)
  • Emerging Opportunity Segment: Production Animals (Animal Type) | Consumables, Reagents & Kits (Product) | Animal Owners/ Producers (End-use) | Cytopathology (Testing Category)

Market Growth Drivers and Industry Trends

Rising pet adoption and preventive animal healthcare increasing demand for routine diagnostic testing

Higher rates of pet ownership and greater awareness of preventive animal healthcare are strengthening demand across the veterinary diagnostics market, as owners increasingly seek regular health screening rather than relying solely on diagnostic testing after symptoms emerge. Routine blood tests, urinalysis, imaging, and other screening procedures support early identification of infections, metabolic disorders, nutritional deficiencies, and chronic conditions, enabling veterinarians to initiate treatment at an earlier stage. The growing emphasis on animal wellness, regular veterinary visits, and preventive care is also encouraging clinics to expand their diagnostic capabilities and incorporate testing into standard health examinations, particularly for companion animals requiring ongoing monitoring.

Growing incidence of zoonotic and livestock diseases accelerating adoption of advanced veterinary diagnostics

The increasing occurrence of diseases affecting both animals and humans is creating a stronger need for rapid and reliable disease surveillance, supporting veterinary diagnostics market growth across companion animal, livestock, and agricultural settings. Zoonotic infections require timely identification to reduce transmission risks, while disease outbreaks among livestock can affect herd health, productivity, food supply, and animal trade. These concerns are encouraging veterinarians, farms, and animal health authorities to adopt diagnostic tools that can identify pathogens more efficiently and support appropriate treatment and containment decisions. Greater attention to biosecurity and disease monitoring is further increasing the role of diagnostic testing in routine livestock management and outbreak response.

Expanding molecular diagnostic capabilities improving accuracy and speed of veterinary disease detection

Advancements in molecular testing are enhancing the ability of veterinary diagnostics market participants to identify pathogens and disease conditions with greater precision and shorter turnaround times. Techniques based on nucleic acid detection can help distinguish closely related infectious agents and detect diseases at earlier stages, supporting more targeted clinical decisions and disease-control measures. Improved laboratory workflows, portable testing technologies, and the broader availability of molecular assays are also making sophisticated diagnostics more practical across veterinary clinics, laboratories, and animal production environments. These capabilities are particularly valuable where rapid identification is necessary to guide treatment, isolate affected animals, or monitor the spread of infectious diseases.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising pet adoption and preventive animal healthcare increasing demand for routine diagnostic testing	2.00%	Moderate	North America, Asia Pacific, Europe	High	Near Term
Growing incidence of zoonotic and livestock diseases accelerating adoption of advanced veterinary diagnostics	1.80%	High	Asia Pacific, North America	High	Mid Term
Expanding molecular diagnostic capabilities improving accuracy and speed of veterinary disease detection	1.60%	Moderate	North America, Europe	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America accounted for 40.55% of the veterinary diagnostics market in 2026, supported by advanced veterinary healthcare infrastructure, high awareness of animal health, and broad adoption of laboratory and point-of-care diagnostic technologies. Increasing emphasis on preventive veterinary care and early disease identification is encouraging greater use of diagnostic testing across companion and production animals. Established veterinary practices, sophisticated laboratory capabilities, and continued integration of digital and molecular diagnostic methods further strengthen regional demand. Growing attention to animal disease surveillance and healthcare outcomes also supports the region’s established market position.

Asia Pacific represents the fastest-growing regional market, driven by expanding veterinary healthcare infrastructure, rising pet ownership, and increasing awareness of animal disease prevention. Growing livestock production is also creating demand for reliable diagnostic tools that can support disease detection, herd health management, and productivity. Improvements in veterinary laboratories, greater accessibility to diagnostic technologies, and increasing investment in animal healthcare are broadening the regional customer base. Rising adoption of preventive veterinary practices is further creating favorable conditions for market expansion.

Key Country Insights

United States

Advanced Diagnostic Adoption

The U.S. veterinary diagnostics market is expanding through greater use of molecular testing, point-of-care diagnostics, and digital laboratory platforms. Veterinary practices in the U.S. increasingly prioritize faster diagnostic workflows that support preventive care and timely treatment decisions for companion and livestock animals.

Japan

Companion Animal Screening

Japan is strengthening the veterinary diagnostics market through increasing demand for routine health screening and early disease detection in companion animals. Diagnostic providers in Japan focus on accurate, minimally invasive testing solutions that integrate efficiently into veterinary clinical practice.

South Korea

Digital Veterinary Solutions

South Korea is integrating digital technologies into veterinary diagnostics to improve laboratory efficiency and diagnostic accuracy. Veterinary clinics in South Korea increasingly adopt automated analyzers and rapid testing platforms to support comprehensive animal healthcare services.

Germany

Precision Laboratory Networks

Germany emphasizes high-quality veterinary diagnostics supported by established laboratory infrastructure and stringent testing standards. Veterinary providers in Germany continue adopting advanced diagnostic technologies that improve disease detection, herd health management, and clinical decision-making.

France

Livestock Health Monitoring

France supports veterinary diagnostics through strong demand from both livestock management and companion animal healthcare. Diagnostic laboratories in France continue expanding testing capabilities that enhance disease surveillance, preventive care, and veterinary treatment planning.

Italy

Integrated Clinical Testing

Italy is reinforcing veterinary diagnostics through broader adoption of laboratory testing across companion animal clinics and livestock operations. Veterinary professionals in Italy increasingly rely on advanced diagnostic tools to improve clinical accuracy and support efficient treatment pathways.

Segment Leadership and Growth Trends

 

Animal Type Segment Analysis: Companion Animals (Largest Segment) vs Production Animals (Fastest-Growing Segment)

Companion animals held the largest share of the veterinary diagnostics market in 2026, accounting for 62.22%. Growing pet ownership and increasing attention to preventive animal healthcare are strengthening demand for diagnostic testing among dogs, cats, and other household animals. Pet owners are becoming more willing to pursue routine health assessments, early disease detection, and laboratory testing, while veterinary practices are expanding their use of diagnostic technologies to support more accurate and timely clinical decisions. The humanization of pets and greater emphasis on maintaining animal health are therefore reinforcing demand across this segment.

Production animals represent the fastest-growing animal type segment as livestock producers place greater emphasis on disease prevention, herd health, productivity, and food safety. Diagnostic testing enables earlier identification of infections and health problems, supporting more effective disease management and reducing the potential impact of illness across animal populations. Increasing adoption of data-driven livestock management and the need to maintain healthy production systems are encouraging broader use of veterinary diagnostic solutions in agricultural settings.

Product Segment Analysis: Consumables, Reagents & Kits (Largest & Fastest-Growing Segment)

Consumables, reagents & kits represented the largest and fastest-growing product segment in the veterinary diagnostics market in 2026, accounting for a 55.61% share. These products are integral to routine diagnostic workflows because testing procedures require recurring supplies for sample preparation, analysis, and detection. Their continued use across veterinary laboratories, clinics, and animal healthcare facilities creates sustained demand, while increasing diagnostic testing volumes and the wider adoption of rapid and laboratory-based testing are supporting further expansion. Growing emphasis on early disease identification and preventive veterinary care is also increasing the frequency with which these products are utilized.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Animal Type	Production Animals, Companion Animals	Companion Animals	Production Animals
Product	Consumables, Reagents & Kits, Equipment & Instruments	Consumables, Reagents & Kits	Consumables, Reagents & Kits
End-use	Reference Laboratories, Veterinarians, Animal Owners/ Producers	Veterinarians	Animal Owners/ Producers
Testing Category	Clinical Chemistry, Microbiology, Parasitology, Histopathology, Cytopathology, Hematology, Immunology & Serology, Imaging, Molecular Diagnostics, Others	Clinical Chemistry	Cytopathology

Competitive Landscape and Market Positioning

Leading companies in the veterinary diagnostics market:

1. IDEXX Laboratories Inc. (United States)

2. Zoetis Inc. (United States)

3. Antech Diagnostics Inc. (United States)

4. FUJIFILM Corporation (Japan)

5. Virbac S.A. (France)

6. Esaote S.p.A. (Italy)

7. Embark Veterinary Inc. (United States)

8. Innovative Diagnostics SAS (France)

9. Agrolabo S.p.A. (Italy)

The veterinary diagnostics market is rapidly evolving with the introduction of AI-assisted testing systems, rapid diagnostic kits, and advanced imaging technologies that improve clinical decision-making. Ongoing research efforts are enhancing diagnostic speed, accuracy, and portability for veterinary applications across companion and livestock animals. Growing emphasis on preventive animal healthcare and disease monitoring is also fueling continuous product development within the sector.

Industry Development/News

Company Name	Date	Key Development
Zoetis	Nov-25	Zoetis acquired Veterinary Pathology Group (VPG), a prominent laboratory network operating across the UK and Ireland. This acquisition significantly expands the company's diagnostics footprint and enhances its capacity to deliver high-quality, specialized diagnostic services, strengthening its competitive positioning within the global animal health diagnostics sector.
KVP International	Dec-25	KVP International acquired SafePath Laboratories and IVD Research (SafePath-IVD). This transaction strengthens the company’s capabilities in veterinary diagnostics, expanding its portfolio of in-vitro diagnostic solutions and diversifying its technological reach across both animal and human health markets.
Eagle Diagnostics	Apr-25	Eagle Diagnostics acquired the Equine Analytical Chemistry Laboratory from the University of Kentucky, rebranding it as Equine Integrity and Anti-Doping Sciences (EQIAS) Labs. This acquisition secures a key facility in anti-doping testing and provides a platform for the company to accelerate research and innovation in specialized equine veterinary diagnostics.
MI:RNA	Dec-25	MI:RNA completed an oversubscribed funding round to accelerate the commercialization of its molecular veterinary diagnostic technologies. By leveraging advanced biomarker modeling for early disease detection, the company is scaling its operational capabilities to meet growing demand for precise, early-stage diagnostics in the animal health market.
IMV Imaging	Sep-25	IMV Imaging formed a strategic partnership with Asto CT to integrate ultrasound, X-ray, and MRI tools with advanced standing CT scanner technology for horses. This collaboration enhances the diagnostic ecosystem for equine and mixed-animal practices, providing a comprehensive, specialized imaging solution for complex veterinary cases.
University of Missouri	Apr-25	The University of Missouri College of Veterinary Medicine initiated development of the Dr. Dan Brown Building to house its Veterinary Medical Diagnostics Laboratory. This expansion of physical infrastructure significantly increases the institution's diagnostic capacity and testing throughput, supporting broader clinical service delivery for veterinary diagnostic providers.
HT VET	Jan-26	HT VET launched an AI-powered, noninvasive diagnostic device for canine cancer detection. This technological integration represents a significant advancement in veterinary oncology, enabling earlier and more accessible disease screening and providing veterinarians with enhanced clinical capabilities for diagnosing dermal and subcutaneous masses.
Zoetis	Sep-24	Zoetis introduced Vetscan OptiCell, a cartridge-based hematology analyzer utilizing AI-driven technology to perform complete blood counts at the point of care. This innovation improves diagnostic efficiency, offering laboratory-quality results with reduced time, space, and cost requirements, thereby optimizing clinical workflow for veterinary practitioners.
Veterinary Specialists of Sydney	Jun-24	Veterinary Specialists of Sydney deployed Australia’s first mobile CT scanner for veterinary use. This expansion of advanced imaging infrastructure improves accessibility to high-resolution diagnostic tools for pets across a wider geographic area, representing a significant improvement in regional diagnostic service delivery and clinical capabilities.
Virginia Equine Imaging	Jul-24	Virginia Equine Imaging integrated the Asto CT Equina standing CT scanner into its clinical operations. This adoption of advanced imaging technology expands the facility’s diagnostic throughput and quality for equine patients, strengthening the provider's competitive advantage in specialized equine medical care.